Smith & Nephew SNATS Inc ADR (SNN)
Smith & Nephew SNATS Inc (NYSE: SNN) is a depositary receipt representing Smith & Nephew plc, a healthcare group headquartered in Watford, United Kingdom. Through its subsidiaries, the issuer develops, manufactures, markets, and sells medical devices and related services in the UK, the US, and other international markets. Its business is organized into three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
The company’s product range includes knee and hip implant systems, trauma and extremities devices, sports medicine repair products, arthroscopic enabling technologies, ear, nose and throat solutions, and a broad set of advanced wound care products. These offerings are used in procedures and treatments for fracture stabilization, joint repair, minimally invasive surgery, and the care of acute and chronic wounds. Smith & Nephew serves healthcare providers and traces its history back to 1856.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-SNN
|
$39.44
|
29.3% Upside
|
Undervalued
|
$33.19
|
8.8% Upside
|
Fair
|
Great
|
2.5%
|
March 1, 2027
|
20.1x
|
2.5x
|
2.0x
|
12.738 B
|
15.767 B
|
23.2%
|
99.0%
|
10.0
|
52.4%
|
134.6%
|